Tris(1-aziridinyl)phosphine Sulfide
CAS Number
52-24-4Synonym
Aziridine, 1,1',1''-phosphinothioylidynetris-;CBC 806495;Girostan;N,N',N''-Tri-1,2-ethanediylphosphorothioic triamide;N,N',N''-Tri-1,2-ethanediylthiophosphoramide;N,N',N''-Triethylenephosphorothioic triamide;N,N',N''-Triethylenethiophosphamide;N,N',N''-Triethylenethiophosphoramide;NCI-C01649;NSC 6396;Oncotepa;Oncothio-tepa;Oncotiotepa;Phosphine sulfide, tris(1-aziridinyl)-; Thiotepa; Phosphorothioic acid triethylenetriamide;Phosphorothioic triamide, N,N',N'
Occurrence/Use
Medicine (antineoplastic), insect sterilant
Cancer Potency Information
| Latest Criteria: | Proposition 65 NSRLs/MADLs |
|---|---|
| Inhalation Unit Risk (μg/cubic meter)-1: | 3.4 E-3 |
| Inhalation Slope Factor (mg/kg-day)-1: | 1.2 E+1 |
| Oral Slope Factor (mg/kg-day)-1: | 1.2 E+1 |
| Comments/References: |
OEHHA 1992. Expedited Cancer Potency Values and Proposed Regulatory Levels for Certain Proposition 65 Carcinogens. |
Proposition 65
Chemical Status
| Cancer: | Currently listed |
|---|
Cancer
| Listed as causing : | Listed as causing: Cancer |
|---|---|
| Date of Listing: |
Safe Harbor Levels
| Cancer | |
| Last NSRL/MADL Revision: | 1992 |
|---|
Documents, Presentations, and Publications
| Cancer: |
|
|---|